Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Relay Therapeutics Inc. Common Stock (RLAY) vs Vanguard S&P 500 Growth Index Fund ETF (VOOG) Price & Performance

Relay Therapeutics Inc. Common StockTrade
Vanguard S&P 500 Growth Index Fund ETFTrade

Price performance (Past 24H)

Key statistics

Relay Therapeutics Inc. Common Stock vs Vanguard S&P 500 Growth Index Fund ETF — how do they compare? Relay Therapeutics Inc. Common Stock trades at $18.14 (market cap $3.82B), while Vanguard S&P 500 Growth Index Fund ETF trades at $87.14 (market cap $27.10B). The key difference: Vanguard S&P 500 Growth Index Fund ETF is far larger — about 7.1× Relay Therapeutics Inc. Common Stock's market cap, and Vanguard S&P 500 Growth Index Fund ETF is trading nearer its 52-week high, Relay Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Relay Therapeutics Inc. Common Stock for 0 Days and Vanguard S&P 500 Growth Index Fund ETF for 54 Days on average.

RLAYVOOG
Market Cap
$3.82B$27.10B
Volume
4,332,0791,178,312
Sector
HealthBroad Market / Factor
52-Week High
$20.75$87.81
52-Week Low
$6.03$65.32
Typical Hold Time
0 Days54 Days
Enterprise Value
$2.93B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Relay Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Vanguard S&P 500 Growth Index Fund ETF

VOOG trades at $87.69, down slightly by 0.14% on the day, with technical indicators showing mixed signals—bullish moving averages but bearish oscillators including an overbought RSI. The ETF, tracking the S&P 500 Growth Index, has delivered strong long-term returns, with recent news highlighting institutional buying and outperformance versus peers. Key support sits at $87, resistance at $88.

Outlook remains positive for long-term growth investors given VOOG's low expense ratio and historical outperformance, though near-term risks include tech sector concentration and market volatility. The ETF's focus on large-cap growth stocks positions it well for sustained appreciation, but investors should be cautious of valuation extremes in growth segments.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

RLAY
100% Buy0% Sell
Avg holding period · 0 Days
VOOG
100% Buy0% Sell
Avg holding period · 54 Days

About Relay Therapeutics Inc. Common Stock

Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.

Read more on RLAY →

About Vanguard S&P 500 Growth Index Fund ETF

VOOG is an index-based ETF that tracks the S&P 500 Growth Index, composed of the growth-oriented companies within the S&P 500. It selects constituents based on three key metrics—sales growth, the ratio of earnings change to price, and momentum—offering a highly liquid and low-cost way to capture the high-performing 'growth slice' of the broader U.S. large-cap market.

Read more on VOOG →